CN1791385A - Homogeneous, thermoreversible alginate films transportation system - Google Patents
Homogeneous, thermoreversible alginate films transportation system Download PDFInfo
- Publication number
- CN1791385A CN1791385A CN 200480014006 CN200480014006A CN1791385A CN 1791385 A CN1791385 A CN 1791385A CN 200480014006 CN200480014006 CN 200480014006 CN 200480014006 A CN200480014006 A CN 200480014006A CN 1791385 A CN1791385 A CN 1791385A
- Authority
- CN
- China
- Prior art keywords
- film
- delivery system
- alginate
- gel
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
Description
相关申请related application
本申请要求登记于2003年4月14目的美国临时申请60/462793的权益。This application claims the benefit of US Provisional Application 60/462793, filed April 14, 2003.
发明领域field of invention
本发明涉及包含均质热可逆凝胶膜的输送体系,其中所述凝胶膜包含(i)成膜量的水溶性热可逆的藻酸盐,以及增塑剂、第二成膜剂、增量剂和pH控制剂中至少任选一种,(ii)活性物质。本发明还涉及所述输送体系的制备方法。The present invention relates to a delivery system comprising a homogeneous thermoreversible gel film, wherein said gel film comprises (i) a film-forming amount of a water-soluble thermoreversible alginate, and a plasticizer, a second film-forming agent, a plasticizer At least one of the dosing agent and the pH control agent is optional, (ii) the active substance. The invention also relates to a method for the preparation of said delivery system.
发明背景Background of the invention
近年来,输送体系越来越多地用在爽口片和洁净片等当中,用来投放口腔护理活性成分等。本发明总体上涉及包含凝胶膜的输送体系,它可用来容纳和输送非常广泛的活性物质。In recent years, delivery systems have been increasingly used in refreshing tablets and cleansing tablets to deliver oral care active ingredients, etc. The present invention generally relates to delivery systems comprising gel membranes which can be used to contain and deliver a very wide variety of active substances.
例如,WO 02/43657公开了无普鲁兰多糖(pullulan)的食用膜组合物的用途,所述组合物包含至少一种成膜剂、至少一种增量填充剂、至少一种增塑剂。这些膜可含有多种物质如药物,并可供许多口腔护理应用,如呼吸清新片。成膜剂被描述为任何的纤维素醚(据称包括:甲基纤维素、乙基纤维素、羟甲基纤维素、羟乙基纤维素、羟丙基甲基纤维素;羧甲基纤维素和其衍生物);改性淀粉(据称包括:酸和酶水解的玉米和土豆淀粉);天然树胶(据称包括阿拉伯胶、瓜耳胶、刺槐豆胶、角叉胶、阿拉伯树胶(acacia)、刺梧桐树胶、茄替胶、黄蓍胶、琼脂、tamrind gum、黄原胶和它们的衍生物);可食用的聚合物(据称包括微晶纤维素、纤维素醚、黄原胶和它们的衍生物);水胶体粉(指包括瓜耳胶、刺槐豆、微晶纤维素、刺云实和它们的衍生物);海藻提取物(据称包括藻酸盐、角叉胶和它们的衍生物);和陆生植物提取物(据称包括魔芋(konjac)、果胶、阿拉伯半乳胶和它们的衍生物)。For example, WO 02/43657 discloses the use of a pullulan-free edible film composition comprising at least one film former, at least one bulk filler, at least one plasticizer . These films can contain various substances such as pharmaceuticals and are used in many oral care applications such as breath freshening tablets. A film former is described as any cellulose ether (said to include: methylcellulose, ethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose; carboxymethylcellulose and its derivatives); modified starches (said to include: acid and enzymatically hydrolyzed corn and potato starches); natural gums (said to include gum arabic, guar gum, locust bean gum, carrageenan, gum arabic ( acacia), karaya, ghatti, tragacanth, agar, tamrind gum, xanthan and their derivatives); edible polymers (said to include microcrystalline cellulose, cellulose ethers, xanthan gums and their derivatives); hydrocolloid powder (referred to include guar gum, locust bean, microcrystalline cellulose, tara and their derivatives); seaweed extract (said to include alginate, carrageenan and their derivatives); and terrestrial plant extracts (said to include konjac, pectin, acacia hemilatex and their derivatives).
WO 00/18365公开用于向口腔传递呼吸除臭剂、抗菌剂和唾液分泌刺激剂的快速口腔溶蚀的膜。用来制造此发明膜的成膜剂据说选自普鲁兰多糖、羟丙基甲基纤维素、羟乙基纤维素、羟丙基纤维素、聚乙烯吡咯烷酮、羟甲基纤维素、聚乙烯醇、藻酸钠、聚乙二醇、黄原胶、黄蓍胶、瓜耳胶、阿拉伯树胶、阿拉伯胶(Arabic gum)、聚丙烯酸、甲基丙烯酸甲酯共聚物、羧乙烯基聚合物、直链淀粉、高级直链淀粉、羟丙基化高级直链淀粉、糊精、果胶、壳多糖、壳聚糖、左聚糖、elsinan、胶原、明胶、玉米蛋白、谷蛋白、大豆蛋白分离物、酪蛋白以及它们的混合物。据说这些膜克服了保持精油相互作用以及用于口腔护理的某些膜中相对高的油含量的问题。WO 00/18365 discloses rapidly mouth erodible films for delivering respiratory deodorants, antimicrobials and salivary stimulators to the oral cavity. The film-forming agent used to make the film of this invention is said to be selected from the group consisting of pullulan, hydroxypropylmethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, polyvinylpyrrolidone, hydroxymethylcellulose, polyethylene Alcohol, Sodium Alginate, Polyethylene Glycol, Xanthan Gum, Tragacanth Gum, Guar Gum, Gum Arabic, Arabic gum, Polyacrylic Acid, Methyl Methacrylate Copolymer, Carboxyvinyl Polymer, Amylose, higher amylose, hydroxypropylated higher amylose, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate substances, casein and their mixtures. These films are said to overcome the problem of maintaining essential oil interactions and the relatively high oil content of some films used in oral care.
发明概述Summary of the invention
在第一种实施方式中,本发明涉及包含均质热可逆凝胶膜的输送体系,其中凝胶膜包含:(i)成膜量的水溶性热可逆藻酸盐,以及增塑剂、第二成膜剂、增量剂和pH控制剂中的至少任选一种;(ii)活性物质。In a first embodiment, the present invention relates to a delivery system comprising a homogeneous thermoreversible gel film, wherein the gel film comprises: (i) a film-forming amount of a water-soluble thermoreversible alginate, and a plasticizer, At least one of two film-forming agents, bulking agents and pH control agents; (ii) active substances.
在第二种实施方式中,本发明涉及制备上述均质凝胶膜输送体系的方法,所述方法包括如下步骤:(i)在提供足够剪切力、温度和保留时间的设备中对藻酸盐,以及增塑剂、第二成膜剂、增量剂和pH控制剂中至少任选一种进行加热、水合、混合、溶解和任选的脱气,形成均质熔融组合物,其中温度等于或高于组合物的溶解温度;(ii)在形成熔融组合物之前或之后加入有效量的活性物质;(iii)在等于或低于其胶凝温度下冷却含活性物质的熔融组合物,形成含活性物质的凝胶膜。In a second embodiment, the present invention relates to a method of preparing the above-mentioned homogeneous gel membrane delivery system, said method comprising the steps of: (i) treating alginic acid in a device providing sufficient shear force, temperature and retention time The salt, and at least one of the plasticizer, the second film forming agent, the bulking agent and the pH control agent are heated, hydrated, mixed, dissolved and optionally degassed to form a homogeneous molten composition, wherein the temperature equal to or higher than the dissolution temperature of the composition; (ii) adding an effective amount of the active substance before or after forming the molten composition; (iii) cooling the molten composition containing the active substance at or below its gelling temperature, Forms a gel film containing the active substance.
附图简述Brief description of the drawings
图1是流体混合设备部分剖开的侧视图,所述设备用来使可用于本发明方法的第一和第二流体与蒸气混合。Figure 1 is a side view, partly broken away, of a fluid mixing apparatus for mixing first and second fluids and vapors useful in the process of the present invention.
发明详述Detailed description of the invention
由褐藻(Phaeophyceae sp.)等衍生而来的藻酸盐是无支链的直链化学聚合物,包含(1-4)连接的β-D-甘露糖醛酸(M)和α-L-古洛糖醛酸(G)残基。藻酸盐不是无规共聚物,而是由交替出现的类似残基嵌段组成,例如MMMM、GGGG和GMGM,它们一般可用来形成藻酸或藻酸盐。Alginate derived from brown algae (Phaeophyceae sp.) etc. is an unbranched linear chemical polymer containing (1-4) linked β-D-mannuronic acid (M) and α-L- Guluronic acid (G) residues. Alginate is not a random copolymer, but consists of alternating blocks of similar residues, such as MMMM, GGGG, and GMGM, which can generally be used to form alginic acid or alginate.
可在本发明中使用的藻酸盐包括藻酸的一价盐,如藻酸钠和藻酸钾,以及藻酸的酯化形式,如藻酸丙二醇酯。本发明所用藻酸盐的定义包括所有这样的酯形式。可用于本发明的藻酸盐的其他例子包括藻酸镁和藻酸3-乙醇胺。这类藻酸盐都可单独使用,也可与本发明的其他藻酸盐组合使用,所述其他藻酸盐可包括少量其他阳离子,只要它们不对凝胶的形成或凝胶膜的均匀度造成不利影响,如下面将要详细讨论的。藻酸盐可从原料中完全、部分被澄清,或不经澄清。Alginates that can be used in the present invention include monovalent salts of alginic acid, such as sodium alginate and potassium alginate, and esterified forms of alginic acid, such as propylene glycol alginate. The definition of alginate used in the present invention includes all such ester forms. Other examples of alginates useful in the present invention include magnesium alginate and 3-ethanolamine alginate. These alginates can be used alone or in combination with other alginates of the present invention, which may include small amounts of other cations, as long as they do not interfere with the formation of the gel or the uniformity of the gel film. Adverse effects, as discussed in detail below. Alginate can be fully, partially clarified, or unclarified from the raw material.
通常认为在钙离子存在下,某些藻酸盐,如藻酸钠产生热不可逆凝胶。令本发明者意外的是,研究发现本发明的这些藻酸盐能产生具有显著膜强度的均质热可逆凝胶膜。此外,通常认为某些藻酸盐,如藻酸丙二醇酯不会发生胶凝。同样令本发明者意外的是,研究发现藻酸丙二醇酯能产生具有显著膜强度的均质热可逆凝胶膜。It is generally believed that certain alginates, such as sodium alginate, produce thermally irreversible gels in the presence of calcium ions. To the surprise of the present inventors, studies have found that these alginates of the present invention are capable of producing homogeneous thermoreversible gel films with significant film strength. Furthermore, it is generally believed that certain alginates, such as propylene glycol alginate, do not gel. Also to the inventors' surprise, studies have found that propylene glycol alginate produces homogeneous thermoreversible gel films with significant film strength.
已知藻酸盐与可以接触到的多价阳离子(离子),如钙离子反应并交联。这种交联会对藻酸盐凝胶膜的膜形成和热可逆性造成不利影响,具体取决于所用多价阳离子;例如,镁离子不会对藻酸盐凝胶膜的热可逆性造成不利影响。因此,重要的一点是,藻酸盐中会对藻酸盐膜的膜形成和热可逆性造成不利影响的这些多价阳离子的含量低于一定程度,以免对藻酸盐体系中膜的形成或热可逆性造成破坏。这种多价阳离子(例如钙离子)的用量通常不高于5.0重量%,更宜少于2.0重量%,更宜少于1.0重量%(基于凝胶膜中藻酸盐的干重),但具体用量可视其他组分、藻酸盐类型和来源的影响,以及螯合剂的使用情况等而发生变化。可以加入足量的螯合剂,以最大程度降低上述有不利影响的多价阳离子,如钙的溶解性(和残余的活性)。Alginate is known to react and cross-link with accessible multivalent cations (ions), such as calcium ions. This crosslinking can adversely affect the film formation and thermoreversibility of alginate gel membranes, depending on the multivalent cations used; for example, magnesium ions do not adversely affect the thermoreversibility of alginate gel membranes Influence. Therefore, it is important that the content of these polyvalent cations in alginate, which can adversely affect the film formation and thermoreversibility of alginate membranes, is below a level that would not affect the film formation or the thermoreversibility of the alginate system. Thermal reversibility causes damage. The amount of such polyvalent cations (such as calcium ions) is usually not higher than 5.0% by weight, more preferably less than 2.0% by weight, more preferably less than 1.0% by weight (based on the dry weight of alginate in the gel film), but The specific amount can vary depending on the influence of other ingredients, the type and source of alginate, and the use of chelating agents. Sufficient chelating agents may be added to minimize the solubility (and residual activity) of the above-mentioned detrimental multivalent cations, such as calcium.
藻酸盐在本发明中以成膜量使用(例如可增加凝胶膜的膜强度的量),它区别于痕量低藻酸盐,后者不能增强膜的性质。因此,举例来说,在本发明的凝胶膜中,成膜量的藻酸盐是能够增加整个膜的膜强度的量。根据应用,这种成膜量通常至少为0.25重量%(基于干凝胶膜),宜为0.5-90重量%,更宜为0.5-50重量%,更宜为0.25-25重量%(基于干凝胶膜)。Alginate is used in the present invention in a film-forming amount (eg, an amount that increases the film strength of a gel film), as opposed to trace low alginate, which does not enhance film properties. Thus, for example, in the gel film of the present invention, the film-forming amount of alginate is an amount capable of increasing the film strength of the entire film. According to the application, this film forming amount is usually at least 0.25% by weight (based on dry gel film), preferably 0.5-90% by weight, more preferably 0.5-50% by weight, more preferably 0.25-25% by weight (based on dry gel film) gel film).
本发明的凝胶膜是均质热可逆膜。这里所用“均质膜”是指这样的膜,用肉眼观察时,膜是均匀的,不含块状物、裂隙、应该溶解而未溶解的颗粒,不存在不溶性颗粒分布不均匀等。“鱼眼”(液体和固体混合状态)或“胶球”(非均匀凝胶结构)不符合这里所用“均质”的定义。The gel films of the present invention are homogeneous thermoreversible films. The "homogeneous film" as used herein refers to a film that is uniform when observed with the naked eye, free of lumps, cracks, undissolved particles that should be dissolved, and non-uniform distribution of insoluble particles. "Fish eyes" (mixed state of liquid and solid) or "gumballs" (non-uniform gel structure) do not meet the definition of "homogeneous" as used herein.
本发明的凝胶膜是均质热可逆凝胶膜。The gel film of the present invention is a homogeneous thermoreversible gel film.
这里所用“热可逆膜”是指这样的膜,它具有熔化温度。这里所用熔化温度是指凝胶膜软化或流动时的温度或温度范围。As used herein, "thermoreversible film" means a film that has a melting temperature. Melting temperature as used herein refers to the temperature or range of temperatures at which the gel film softens or flows.
这里所用词组“凝胶膜”是指由结构化藻酸盐形成的薄膜。成胶组合物的特征是胶凝温度,熔融物料必须冷却到此温度以下才能形成自支撑结构。任选地,熔融物质可热浇铸,然后冷却,并通过干燥进一步浓缩固体(有控制地除去水分),直到由凝胶组合物形成凝胶膜。热可逆凝胶膜的熔化温度高于其胶凝温度。The phrase "gel film" as used herein refers to a thin film formed from structured alginate. Gelled compositions are characterized by the gelation temperature below which the molten mass must be cooled to form a self-supporting structure. Optionally, the molten mass can be cast hot, then cooled, and the solid further concentrated by drying (controlled removal of water) until a gel film is formed from the gel composition. The melting temperature of a thermoreversible gel film is higher than its gelling temperature.
本发明的凝胶膜包含一种活性物质。能包含在凝胶膜中的活性物质是选自口腔护理剂、呼吸清新剂、药剂、营养剂、唾液分泌刺激剂、维生素、矿物质、色剂、化妆品成分、农用活性物、甜味剂、调味剂、芳香剂或食品中至少一种。The gel film of the present invention comprises an active substance. The active substances that can be contained in the gel film are selected from the group consisting of oral care agents, breath fresheners, medicaments, nutritional agents, salivation stimulators, vitamins, minerals, colorants, cosmetic ingredients, agricultural actives, sweeteners, At least one of flavoring agent, aroma agent or food.
本发明的均质热可逆凝胶膜可任选包含增塑剂、第二成膜剂、增量剂和pH控制剂中的至少一种。加入凝胶膜中的组分及其加入量可根据藻酸盐输送体系的所需特点而变化。The homogeneous thermoreversible gel film of the present invention may optionally contain at least one of a plasticizer, a second film forming agent, an extender and a pH control agent. The components incorporated into the gel film and the amounts added may vary according to the desired characteristics of the alginate delivery system.
这种增塑剂的例子包括多元醇,如甘油、山梨糖醇、麦芽糖醇、乳糖醇、果糖、玉米淀粉、聚葡萄糖、增溶油和聚亚烷基二醇,如聚乙二醇和丙二醇。根据输送体系所需的弹性,这种增塑剂的用量一般占干膜中包括水在内的所有组分的至少5重量%,至少10重量%,宜为至少20重量%,更宜为至少30重量%。所述输送体系可以不含任何增塑剂。Examples of such plasticizers include polyhydric alcohols such as glycerin, sorbitol, maltitol, lactitol, fructose, corn starch, polydextrose, solubilizing oils and polyalkylene glycols such as polyethylene glycol and propylene glycol. Depending on the desired elasticity of the delivery system, such plasticizers are generally used in an amount of at least 5% by weight, at least 10% by weight, preferably at least 20% by weight, more preferably at least 30% by weight. The delivery system may be free of any plasticizers.
可用于本发明的第二成膜剂的例子包括淀粉、淀粉水解产物(hydrozylate)、淀粉衍生物、纤维素胶、水胶体、烷基纤维素醚或改性烷基纤维素醚中的至少一种。水胶体的例子包括以下物质中的至少一种:κ角叉胶;κ-2角叉胶;ι角叉胶;甘露聚糖胶如刺槐豆胶或瓜耳胶,包括低粘度瓜耳胶;右旋糖苷;普鲁兰多糖;吉兰糖胶(gellan)(包括高酰基和低酰基吉兰糖胶);果胶和它们未经充分改性的形式以及它们的组合。这里所用κ-2角叉胶所具有的3∶6-无水半乳糖-2-硫酸酯(3∶6AG-2S)与3∶6-脱水半乳糖(3∶6AG)含量的摩尔比为25-50%,ι角叉胶所具有的3∶6AG-2S与3∶6AG含量的摩尔比为80-100%,κ角叉胶所具有的3∶6AG-2S与3∶6AG含量的摩尔比少于κ-2角叉胶。例如,来自κ角叉胶常用海藻来源耳突麒麟菜(Eucheuma cottonii)的κ角叉胶所具有的3∶6AG-2S与3∶6AG含量的摩尔比约小于10%;来自ι角叉胶常用海藻来源刺麒麟菜(Eucheuma spinosum)的ι角叉胶所具有的3∶6AG-2S与3∶6AG含量的摩尔比约大于85%。κ-2角叉胶可得自例如杉藻(Gigartina skottsbergii)。κ角叉胶、κ-2角叉胶和ι角叉胶在结构和功能上彼此不同。如果需要将ι、κ或κ-2角叉胶用作第二成膜剂,在分子量减少的角叉胶占溶液总重1.5%的0.10M氯化钠溶液中,这种角叉胶在75℃下的粘度为19cps或更小,更宜小于10cps。此粘度测定可用Brookfield LVF(Brookfield Engineering Laboratories,Inc.)粘度计进行,采用#1锭子,转速为60rpm,转6圈后测定粘度。可用于本发明的烷基纤维素醚的一个例子是羟乙基纤维素。可用于本发明的改性烷基纤维素醚的例子包括羟丙基纤维素和羟丙基甲基纤维素。应当注意,某些第二成膜剂,如角叉胶,可能包含对角叉胶和/或藻酸盐的凝胶性质和膜强度有正面影响和负面影响的阳离子。这种有益阳离子包括钾离子、镁离子和铵离子。这些阳离子可存在于角叉胶当中,也可从其他有机或无机源加入。这些有益阳离子的含量可占凝胶膜(包括水)中藻酸盐干重的20%以下。此含量可根据体系中的组分和所需熔化和密封温度而变化。Examples of second film formers that can be used in the present invention include at least one of starch, starch hydrozylate, starch derivative, cellulose gum, hydrocolloid, alkyl cellulose ether or modified alkyl cellulose ether kind. Examples of hydrocolloids include at least one of the following: kappa carrageenan; kappa-2 carrageenan; iota carrageenan; mannan gums such as locust bean gum or guar gum, including low viscosity guar gum; Dextran; pullulan; gellan (including high acyl and low acyl gellan gum); pectin and their less substantially modified forms and combinations thereof. The κ-2 carrageenan used here has a molar ratio of 3:6-anhydrogalactose-2-sulfate (3:6AG-2S) to 3:6-anhydrogalactose (3:6AG) content of 25 -50%, iota carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content 80-100%, kappa carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content less than kappa-2 carrageenan. For example, kappa carrageenan from Eucheuma cottonii, a common seaweed source for kappa carrageenan, has a molar ratio of 3:6AG-2S to 3:6AG content of less than about 10%; The iota carrageenan of the seaweed source Eucheuma spinosum has a molar ratio of 3:6 AG-2S to 3:6 AG content of greater than about 85%. Kappa-2 carrageenan can be obtained, for example, from Gigartina skottsbergii. Kappa carrageenan, kappa-2 carrageenan, and iota carrageenan are structurally and functionally distinct from each other. If it is desired to use iota, kappa or kappa-2 carrageenan as the second film-forming agent, in a 0.10M sodium chloride solution in which the molecular weight reduced carrageenan accounts for 1.5% of the total solution weight, this carrageenan is at 75 The viscosity at °C is 19 cps or less, more preferably less than 10 cps. This viscosity measurement can be carried out with a Brookfield LVF (Brookfield Engineering Laboratories, Inc.) viscometer, using a #1 spindle with a rotation speed of 60 rpm, and measuring the viscosity after 6 turns. An example of an alkyl cellulose ether useful in the present invention is hydroxyethyl cellulose. Examples of modified alkyl cellulose ethers useful in the present invention include hydroxypropylcellulose and hydroxypropylmethylcellulose. It should be noted that certain secondary film formers, such as carrageenan, may contain cations that have both positive and negative effects on the gel properties and film strength of the carrageenan and/or alginate. Such beneficial cations include potassium, magnesium and ammonium ions. These cations may be present in the carrageenan or may be added from other organic or inorganic sources. The content of these beneficial cations can account for less than 20% of the dry weight of alginate in the gel film (including water). This level can vary depending on the components in the system and the desired melting and sealing temperature.
其他阳离子,如钙(上面曾提到)、铝和铬离子可与藻酸盐发生不利的交联,且/或对角叉胶的稳定性有不利影响,应当使其含量保持最低,如低于干凝胶膜(包括水)中藻酸盐干重的5%,低于2%,低于1%。Other cations, such as calcium (mentioned above), aluminum and chromium ions can detrimentally cross-link alginate and/or adversely affect the stability of carrageenan and should be kept to a minimum, e.g. low 5%, less than 2%, less than 1% of the dry weight of alginate in the xerogel film (including water).
藻酸盐可以是凝胶膜中的唯一成膜剂。如果本发明凝胶膜包含第二成膜剂,则藻酸盐的含量可占干凝胶膜中成膜剂总量的至少10重量%,至少40重量%,至少60重量%,或至少80重量%。Alginate can be the only film former in the gel film. If the gel film of the present invention comprises a second film former, the content of alginate may be at least 10% by weight, at least 40% by weight, at least 60% by weight, or at least 80% by weight of the total amount of film former in the dry gel film. weight%.
增量剂的例子包括微晶纤维素、微晶淀粉、改性和未改性淀粉、淀粉衍生物、菊粉、淀粉水解产物(hydrozylate)、糖、玉米糖浆和聚葡萄糖。在本说明书和权利要求中所用术语“改性淀粉”包括这样一些淀粉,如羟丙基化淀粉、酸稀释淀粉等。可用于本发明的改性淀粉的例子包括Pure CoteTM B760、B790、B793、B795、M250和M180,Pure-DentTM B890和Pure-SetTM B965(全部购自GrainProcessing Corporation,Muscantine,Iowa),以及C AraTexTM 75701(购自Cerestar,Inc.)。淀粉水解产物(hydrozylate)的例子包括麦芽糖糊精,亦称糊精。未改性淀粉,如马铃薯淀粉,当与本发明范围内的水胶体组合使用时,也可增加膜强度。一般地,改性淀粉是对淀粉进行处理得到的产品,例如酸处理淀粉、酶处理淀粉、氧化淀粉、交联淀粉和其他淀粉衍生物。改性淀粉宜为这样的衍生物,即侧链用亲水或憎水基团进行改性,形成侧链之间存在强相互作用的更为复杂的结构。Examples of bulking agents include microcrystalline cellulose, microcrystalline starch, modified and unmodified starches, starch derivatives, inulin, starch hydrozylates, sugars, corn syrup, and polydextrose. The term "modified starch" as used in the specification and claims includes such starches as hydroxypropylated starch, acid thinned starch and the like. Examples of modified starches useful in the present invention include Pure Cote ™ B760, B790, B793, B795, M250 and M180, Pure-Dent ™ B890 and Pure-Set ™ B965 (all available from Grain Processing Corporation, Muscantine, Iowa), and C AraTex ™ 75701 (available from Cerestar, Inc.). Examples of starch hydrozylates include maltodextrin, also known as dextrin. Unmodified starches, such as potato starch, can also increase film strength when used in combination with hydrocolloids within the scope of the present invention. Generally, modified starch is a product obtained by treating starch, such as acid-treated starch, enzyme-treated starch, oxidized starch, cross-linked starch and other starch derivatives. The modified starch is preferably a derivative in which the side chains are modified with hydrophilic or hydrophobic groups to form a more complex structure with strong interactions between the side chains.
本发明中增量剂的用量通常占干膜重量的0-20重量%,但若需要,根据输送体系的用途,也可用更多的量,例如至少为干膜的20%,更宜为至少30%。注意到,淀粉、淀粉衍生物和淀粉水解产物可以具有多重功能。也就是说,除了用作增量剂外,它们也可用作第二成膜剂。如果像这样用作增量剂和第二成膜剂,它们的用量通常占干凝胶膜重量的至少10重量%,宜为至少20重量%。The amount of extender used in the present invention is usually 0-20% by weight of the dry film weight, but if necessary, according to the use of the delivery system, it can also be used in more amounts, such as at least 20% of the dry film, more preferably at least 30%. Note that starch, starch derivatives and starch hydrolysates can have multiple functions. That is, in addition to their use as extenders, they can also be used as secondary film formers. If used as such as extenders and secondary film formers, they are generally present in amounts of at least 10% by weight of the dry gel film, preferably at least 20% by weight.
用于本发明的pH控制剂的例子包括碱如氢氧化物、碳酸盐、柠檬酸盐和磷酸盐。pH控制剂可用来提高凝胶膜的稳定性。对于某些包含第二成膜剂的组合物,pH控制剂可以选择作为有益阳离子源,如钾或铵。pH控制剂的用量占干凝胶膜的0-4重量%,更宜为0-2重量%。Examples of the pH controlling agent used in the present invention include bases such as hydroxides, carbonates, citrates and phosphates. pH control agents can be used to increase the stability of the gel film. For certain compositions comprising a secondary film former, a pH control agent may be selected as a source of beneficial cations, such as potassium or ammonium. The pH control agent is used in an amount of 0-4% by weight of the dry gel film, more preferably 0-2% by weight.
研究发现,本发明干凝胶膜(例如至少含80%的固体)的断裂力为(例如)至少250g,至少1000g,至少2500g,至少4000g,至少5000g,至少6000g,可用Texture Analyzer TA-108S Mini Film Test Rig测定。此外,测量表明,本发明干燥膜的断裂力超过7000和8000g。Studies have found that the breaking force of the xerogel film of the present invention (for example, containing at least 80% solids) is (for example) at least 250g, at least 1000g, at least 2500g, at least 4000g, at least 5000g, at least 6000g, available Texture Analyzer TA-108S Mini Film Test Rig determination. In addition, measurements have shown that the breaking force of the dry film of the present invention exceeds 7000 and 8000 g.
研究发现,本发明膜的固体含量占凝胶膜中所有组分的至少50%,至少60%,至少70%,至少80%,至少90%。可以理解,干凝胶膜中仍有多达15%,10%,5%的水强烈地结合在固体上。It has been found that the film of the present invention has a solids content of at least 50%, at least 60%, at least 70%, at least 80%, at least 90% of all components in the gel film. It is understood that as much as 15%, 10%, 5% of the water in the xerogel film is still strongly bound to the solid.
本发明凝胶膜也可包含着色剂和调味剂,如糖、玉米糖浆、果糖、蔗糖等,而不管是否存在其他组分,如增塑剂、增量剂、第二成膜剂等。本发明凝胶膜的一种实施方式包含本发明所述藻酸盐、调味剂和水,组成高固体含量体系,例如固体含量超过50%,60%,65%,75%,80%,85%,90%。The gel films of the present invention may also contain coloring and flavoring agents, such as sugar, corn syrup, fructose, sucrose, etc., regardless of the presence or absence of other components such as plasticizers, bulking agents, secondary film formers, and the like. One embodiment of the gel film of the present invention comprises the alginate of the present invention, flavoring agent and water to form a high solid content system, for example, the solid content exceeds 50%, 60%, 65%, 75%, 80%, 85% %, 90%.
本发明膜可以包含非热可逆性树胶。但是,为了不对本发明凝胶膜的均质性和热可逆性造成不利影响,这种非热可逆性膜的含量应当少于藻酸盐重量的50重量%,宜少于40重量%,更宜少于30重量%。这种非热可逆性树胶的例子包括交联和部分交联的树胶,如钙固化(例如交联)果胶或藻酸盐。若不存在二价阳离子,钙活性藻酸盐和果胶,以及它们精制程度稍差的形式可考虑作为热可逆性胶。The films of the present invention may comprise non-thermoreversible gums. However, in order not to adversely affect the homogeneity and thermoreversibility of the gel film of the present invention, the content of this non-thermoreversible film should be less than 50% by weight of the alginate weight, preferably less than 40% by weight, more preferably Preferably less than 30% by weight. Examples of such non-thermoreversible gums include cross-linked and partially cross-linked gums, such as calcium-cured (eg, cross-linked) pectins or alginates. In the absence of divalent cations, calcium-active alginates and pectins, and their less refined forms, are considered thermoreversible gums.
本发明的膜通常用这样的工艺制备,该工艺采用能提供足够高的剪切力、温度(高于胶凝温度)和足够长的保留时间的设备,以得到均质熔融组合物,冷却后形成凝胶。这通常是在设备中通过对组合物进行加热、水合、混合、增溶和任选的脱气来完成的。这种设备的例子有Ross混合器、Stephan处理机、挤塑机、普通射流锅炉和图1所示的流体混合设备。Ross混合器、Stephan处理机和普通射流锅炉很容易购得。在冷却之前,可将熔融物送入泵、混合器或排气器中的至少一个,如挤塑机。注意,作为本发明另一个方面,熔融物不必在步骤(i)达到均质。即,当使用另外的设备如混合器、泵和/或排气室时,可以在将熔融组合物送入混合器,泵或排气室中至少一个之前或之后,得到均质熔融物,只要熔融物在胶凝前达到均质。可将挤出的熔融物送入成膜或成形设备(例如展涂箱),以利于均匀浇铸连续的膜,或者将挤出的熔融物送进模具,以便从熔融物输送设备直接形成膜或成形的挤塑物。必须注意,在限定流动/形成凝胶结构开始之前,要保持熔融物的状态。可采用绝热和预热(用以维持合适的温度)输送软管,确保熔融物能够流动,直到所需的凝胶膜成形过程开始进行。可以用其他处理方法(如预热卸料/活塞状头(discharge/plunger-likehead),像在Ross处理系统中所看到的那样)迫使(通过压力)熔融物通过上面提到的输送软管。其他绝热措施也可帮助维持熔融物的温度,如移走混合设备后立即在熔融物表面盖上特氟隆片。注意,作为本发明的另一个方面,熔融物不必在步骤(i)达到完全均质。即,当使用另外的设备如混合器、泵和/或排气器时,可以在将熔融组合物送入混合器,泵或排气室中至少一个之前或之后,得到均质熔融物,只要熔融物在胶凝前达到均质即可。The films of the present invention are generally prepared by a process employing equipment capable of providing sufficiently high shear, temperature (above the gelation temperature) and sufficiently long residence time to obtain a homogeneous molten composition which, after cooling Form a gel. This is usually done in the plant by heating, hydrating, mixing, solubilizing and optionally degassing the composition. Examples of such equipment are Ross mixers, Stephan processors, extruders, common jet boilers and the fluid mixing equipment shown in Figure 1. Ross mixers, Stephan processors and common jet boilers are readily available. Prior to cooling, the melt may be sent to at least one of a pump, mixer, or exhaust, such as an extruder. Note that, as another aspect of the invention, it is not necessary for the melt to be homogeneous in step (i). That is, when using additional equipment such as a mixer, a pump and/or an exhaust chamber, a homogeneous melt can be obtained either before or after feeding the molten composition into at least one of the mixer, pump or exhaust chamber, as long as The melt reaches homogeneity before gelling. The extruded melt can be fed to film-forming or forming equipment (such as a spreader box) to facilitate uniform casting of continuous films, or the extruded melt can be fed to a die to form a film directly from melt delivery equipment or Shaped extrusions. Care must be taken to maintain the melt state until the defined flow/gel structure formation begins. The delivery hose can be insulated and preheated (to maintain the proper temperature) to ensure that the melt can flow until the desired gel film formation process begins. The melt can be forced (by pressure) through the transfer hose mentioned above with other processing methods (such as preheated discharge/plunger-like head (discharge/plunger-likehead), as seen in the Ross processing system) . Other insulation measures can also help maintain the temperature of the melt, such as covering the surface of the melt with Teflon sheets immediately after removing the mixing equipment. Note that, as another aspect of the invention, it is not necessary for the melt to be completely homogeneous in step (i). That is, when using additional equipment such as a mixer, pump and/or exhauster, a homogeneous melt can be obtained before or after feeding the molten composition into at least one of the mixer, pump or exhaust chamber, as long as It is sufficient for the melt to be homogeneous before gelling.
这里所用“流体混合设备”是指图1中的设备。图1所示为流体混合设备10。流体混合设备10用来混合蒸气2与第一流体或浆液4和第二流体或浆液6,产生熔融物或混合浆料8。As used herein, "fluid mixing device" refers to the device in FIG. 1 . FIG. 1 shows a
流体混合设备10包含第一室20,室中配有让蒸气2进入室20的第一进口22,蒸气2排出室20的喷嘴的端部24,安置在喷嘴端部24上的喷嘴阀门或干部26。促动器30与第一室20相连,用以控制第一流体(蒸气)2在喷嘴端部24的出口速率或出口压力。促动器30可以是Fisher Controls U.S.A.生产的类型。The
流体混合设备10还包含第二混合室40,它在第一室20的喷嘴端部24与第一室20相连。第二室40包含让第一流体4进入第二室40的第二进口42和让第二流体6进入第二室40的第三进口44。进口42和44位于第一进口22的下游。如图1所示,第二进口42和第三进口44位于同一平面内,在径向上彼此相望,最好是对于混合设备10的中心轴Y完全相对(即相差180°)。第二室40构成了总体上呈圆筒形的混合室52,它接着构成沿混合室52的轴长度方向延伸的流动通道,从混合室52的进气端54开始,到室52的出口端56为止。促动器30可使进气端54上的喷嘴阀门26在密封位置和开启位置之间移动,以控制蒸气2进入混合室52的流动速率。The
第一室20的喷嘴端24将蒸气2导入混合室52的进气端54。第二进口42和第三进口44沿径向分别将第一流体4和第二流体6导入混合室52。蒸气2、第一流体4和第二流体6在混合室52中混合,形成熔融物或混合物8,然后从混合室52出来。接下来,熔融物8可形成成形制品或形成膜,例如将混合物8浇铸到冷却鼓上,或者让混合物8通过挤塑机。The nozzle end 24 of the
流体混合设备10适合制备用于成膜的混合物,特别是用来制备可食用的输送体系的可食用膜。一般将不相容的膜组分放在不同的流体进气中,在流体混合设备的混合室52内,这些互不干扰的组分在蒸气注射界面上立即碰到一起。虽然图1示出了蒸气、第一和第二流体的三个进口,但也可以再提供一个或多个进口,供一个或多个其他流体使用。流体混合设备10的室20、40和其他部件宜由高级不锈钢制造。The
也可用凝胶膜改变剂型的溶出性质。例如,本发明的凝胶膜中可加入能产生固体剂型的组分,这种剂型具有即释、肠释或缓释的能力。“即释”、“缓释”和“肠释”的定义可在美国药典中找到,在此引为参考。Gel films can also be used to modify the dissolution properties of the dosage form. For example, the gel film of the present invention may incorporate components that produce a solid dosage form with immediate, enteric or sustained release capabilities. Definitions of "immediate release", "sustained release" and "enteric release" can be found in the United States Pharmacopoeia, which is incorporated herein by reference.
下面通过实施例更详细地描述本发明,但应当理解,本发明不受限于这些实施例。除非另有说明,所有的份、百分数、比例等都就重量而言。The present invention will be described in more detail by examples below, but it should be understood that the present invention is not limited to these examples. Unless otherwise indicated, all parts, percentages, ratios, etc. are by weight.
实施例Example
除非另有说明,下面的过程是用来制备和测定实施例1-3中的材料和膜的。Stephan UMC5处理机是实验室用混合设备,可对将在实验室中浇铸成膜的制剂进行适当的高速剪切混合、加热和脱气。合适的批处理规模是1500g。Unless otherwise stated, the following procedures were used to prepare and test the materials and films of Examples 1-3. The Stephan UMC5 Processor is laboratory mixing equipment for proper high shear mixing, heating and degassing of formulations to be cast into films in the laboratory. A suitable batch size is 1500g.
这样制备淀粉的水分散体:将任何盐/缓冲剂和pH调节剂溶解在去离子水中,加入淀粉和/或麦芽糖糊精(M100),混合,直到它们溶解/分散。Pure CoteB760淀粉可购自Grain Processing Corporation,Muscatine,Iowa。在StephanUMC5处理机中制备水胶体混合物:预混合增塑剂直至均匀,分批加入预混合干燥水胶体,每次加入后以200rpm的速度搅拌约30秒。用Sorbitol Special和甘油作增塑剂。Sorbitol Special是山梨糖醇与山梨糖醇酐的水溶液,固体含量为76%,由SPI Polyols,Inc.(New Castle,DE)生产。Aqueous dispersions of starch are prepared by dissolving any salts/buffers and pH adjusters in deionized water, adding starch and/or maltodextrin (M100), mixing until they are dissolved/dispersed. Pure Cote (R) B760 starch is commercially available from Grain Processing Corporation, Muscatine, Iowa. Prepare the hydrocolloid mixture in a Stephan UMC5 processor: pre-mix the plasticizer until homogeneous, add the pre-mixed dry hydrocolloid in batches, stirring at 200 rpm for about 30 seconds after each addition. Sorbitol Special and glycerin were used as plasticizers. Sorbitol Special is an aqueous solution of sorbitol and sorbitan at 76% solids, manufactured by SPI Polyols, Inc. (New Castle, DE).
在无水水胶体混合物中加入淀粉分散体,以300rpm的速度搅拌5分钟。机械搅拌速度增加到2100rpm,在搅拌下将混合物加热到85-95℃。当达到目标温度后,搅拌混合物30分钟,然后在连续搅拌下将样品保持在真空下(50-60巴)45分钟。Add the starch dispersion into the anhydrous hydrocolloid mixture and stir for 5 minutes at a speed of 300 rpm. The mechanical stirring speed was increased to 2100 rpm and the mixture was heated to 85-95°C with stirring. When the target temperature was reached, the mixture was stirred for 30 minutes and then the sample was kept under vacuum (50-60 bar) for 45 minutes with continuous stirring.
在真空和目标温度下的保持时间结束后,将样品倒入经过预热的广口1夸脱Mason玻璃罐中。记录温度和pH。用Brookfield LVF粘度计测定热样品的粘度。After the hold time at vacuum and target temperature was complete, the samples were poured into preheated wide mouth 1 quart Mason glass jars. Record temperature and pH. The viscosity of the hot samples was measured with a Brookfield LVF viscometer.
取出小部分样品,冷藏过夜,然后用Atago E系列手持式折射仪(Gardco,Pompano Beach,FL)测定凝胶/熔体性质和固体含量。将一小块经过冷藏的凝胶放在丝线支架上,支架固定在试管中,使凝胶块接触不到试管壁,由此测定凝胶的熔化温度。用铝箔覆盖试管,铝箔上开一小孔,以便用数字温度探头测定凝胶的温度。将试管浸没在加热浴中,使凝胶块处在大约100℃的热水浴表面以下。对于熔化温度高于90℃的样品,采用硅油浴。当凝胶样品看上去变湿、变软并能够搅动时,记录熔化温度(记下温度范围)。样品一旦熔化,将试管转移到装有冷自来水(15℃)的第二个烧杯中。在样品冷却的过程中,用温度探针测定温度,并检查样品表面,看样品是否开始胶凝。胶凝温度是样品在冷却时不再流动,以填满探头戳出的凹痕时的温度。A small aliquot of the sample was removed, refrigerated overnight, and gel/melt properties and solids content were determined with an Atago E-Series handheld refractometer (Gardco, Pompano Beach, FL). The melting temperature of the gel is determined by placing a small piece of refrigerated gel on a wire stand fixed in the test tube so that the gel piece does not touch the wall of the test tube. Cover the test tube with aluminum foil with a small hole for the temperature of the gel to be measured with a digital temperature probe. Submerge the test tube in a heating bath so that the gel mass is below the surface of the hot water bath at approximately 100°C. For samples with a melting temperature higher than 90 °C, use a silicone oil bath. When the gel sample appears wet, soft and stirrable, record the melting temperature (note the temperature range). Once the sample had melted, the tube was transferred to a second beaker filled with cold tap water (15°C). While the sample is cooling, measure the temperature with a temperature probe and check the surface of the sample to see if the sample is starting to gel. The gelation temperature is the temperature at which the sample no longer flows when cooled to fill the indentation made by the probe.
接下来,用带有3mm宽间隙的刮板将热样品浇铸到177mm×177mm×5mm金属板上,金属板上预先喷有PAM(卵磷脂),以方便移动膜材料。盖上涂布凝胶的金属板,以防浇铸膜中的水分散失,并要冷藏(低于8℃)至少半小时,然后将膜取下进行测试。成膜的过程中不需要冷藏。在40℃鼓风炉中干燥涂层板,制备干燥膜条。膜在40℃干燥2小时,达到平均固体含量约为60%。如果膜在40℃干燥过夜,则一般得到80%或以上的固体含量。除非另有说明,一般在室温下(约20℃)测定样品性质。干膜的固体百分数通过其固体制剂的浇铸膜与干膜的重量差来确定。用Texture Analyzer TA-108S Mini Film Test Rig测定浇铸膜条和干膜条的断裂力(BF)。Next, the hot samples were cast with a squeegee with a 3 mm wide gap onto a 177 mm x 177 mm x 5 mm metal plate pre-sprayed with PAM (lecithin) to facilitate the movement of the membrane material. The gel-coated metal plate was covered to prevent water loss from the cast film and kept refrigerated (below 8°C) for at least half an hour before the film was removed for testing. Refrigeration is not required during film formation. The coated panels were dried in a 40°C blast oven to prepare dry film strips. The film was dried at 40°C for 2 hours to an average solids content of approximately 60%. Solids contents of 80% or more are generally obtained if the film is dried overnight at 40°C. Unless otherwise stated, sample properties were generally determined at room temperature (about 20°C). The percent solids of a dry film is determined by the weight difference between the cast film and the dry film of its solid formulation. The breaking force (BF) of cast and dry film strips was determined with a Texture Analyzer TA-108S Mini Film Test Rig.
除非另有说明,Maltrin M100购自Grain Processing Corporation,PureCote B760购自Grain Processing Corporation,Sorbitol Special购自SPIPolyols,甘油购自VWR(EP/USP级)。Unless otherwise stated, Maltrin M100 was purchased from Grain Processing Corporation, PureCote B760 was purchased from Grain Processing Corporation, Sorbitol Special was purchased from SPI Polyols, and glycerin was purchased from VWR (EP/USP grade).
实施例1Example 1
表I列出了用藻酸钠和Indian Gum Industries Ltd.生产的低粘性瓜耳胶Edicol ULV 50的混合物制备的凝胶膜的组成和性质。ProtanalLFR5/60,ProtanalLF20/40和ProtanalSF120 RB是购自FMC公司(Philadelphia,PA)的藻酸钠。Table I lists the composition and properties of gel films prepared with a mixture of sodium alginate and low viscosity guar gum Edicol ULV 50 produced by Indian Gum Industries Ltd. Protanal® LFR5/60, Protanal® LF20/40 and Protanal® SF120 RB are sodium alginate available from FMC Corporation, Philadelphia, PA.
表I
增加藻酸钠的分子量对整个膜的结构有利,可提高膜的强度(实施例1-1、1-2和1-3)。上表所列熔化温度是通过油浴加热凝胶膜得到的。受热之后,它们发生软化,可以搅动。冷却时,在室温以上的温度下就形成凝胶。Increasing the molecular weight of sodium alginate is beneficial to the structure of the whole membrane and can improve the strength of the membrane (Example 1-1, 1-2 and 1-3). The melting temperatures listed above were obtained by heating the gel film in an oil bath. When heated, they soften and can be stirred. Upon cooling, gels form at temperatures above room temperature.
实施例2Example 2
采用两种藻酸钾:KAHG是从海带(Laminaria hyperborean)提取的藻酸的钾盐,含有较多古洛糖醛酸(G)单元;KAHM是从Lessonia nigrescens提取的藻酸的钾盐,含有较多甘露糖醛酸(M)单元。利用1%水溶液在25℃测定时,KAHG和KAHM的粘度分别是5cps和12cps。Two kinds of potassium alginates are used: KAHG is the potassium salt of alginic acid extracted from Laminaria hyperborean, which contains more guluronic acid (G) units; KAHM is the potassium salt of alginic acid extracted from Lessonia nigrescens, which contains more Polymannuronic acid (M) unit. The viscosities of KAHG and KAHM are 5 cps and 12 cps respectively when measured with 1% aqueous solution at 25°C.
与藻酸根结合的钾阳离子有利于引发κ角叉胶和/或κ-2角叉胶与藻酸盐形成均质浇铸及固化膜结构的过程。κ角叉胶是从Kappaphycus alaverei(耳突麒麟藻(Eucheuma cottonii))经碱处理得到的澄清提取物。使用的所有水胶体中的二价阳离子含量均较低,如表II所示。Potassium cations bound to alginate are beneficial to initiate the process of homogeneous casting and curing film structure of kappa carrageenan and/or kappa-2 carrageenan and alginate. Kappa carrageenan is an alkaline-treated clarified extract from Kappaphycus alaverei (Eucheuma cottonii). All hydrocolloids used were low in divalent cation content, as shown in Table II.
表II:水胶体中阳离子的含量
表III列出了用藻酸钾和其他成膜剂,如κ角叉胶和Indian Gum Industries生产的低粘性瓜耳胶Edicol ULV 50的混合物形成的膜的组成和特性。Table III lists the composition and properties of the films formed with mixtures of potassium alginate and other film formers such as kappa carrageenan and low viscosity guar gum Edicol ULV 50 produced by Indian Gum Industries.
表III 用低粘性瓜耳胶、藻酸钾和角叉胶制备的膜
结果表明,不管是含有较多的甘露糖醛酸根还是较多的古洛糖醛酸根,或者二者均较多,藻酸钾与κ角叉胶和瓜耳胶组合后,能形成有利的相互作用。进一步改变藻酸盐与第二成膜剂的重量比,改变工艺条件,同样可用来浇铸成高固体含量(>80%)熔融物,成形且冷却的凝胶膜,也可进一步加工。The results showed that the combination of potassium alginate with kappa carrageenan and guar gum, regardless of whether it contained more mannuronate, more guluronate, or both, formed a favorable interaction. effect. Further changing the weight ratio of alginate to the second film-forming agent and changing the process conditions can also be used to cast a high solid content (>80%) melt, and the formed and cooled gel film can also be further processed.
实施例3Example 3
表IV列出了用藻酸丙二醇酯和κ角叉胶制备的凝胶膜的组成和性质。Protanal酯BV4830是藻酸丙二醇酯,可购自FMC公司(Philadelphia,PA)。HEC是羟乙基纤维素。κ角叉胶如上面实施例2所述。Table IV lists the composition and properties of the gel films prepared with propylene glycol alginate and kappa carrageenan. Protanal (R) ester BV4830 is propylene glycol alginate available from FMC Corporation (Philadelphia, PA). HEC is hydroxyethylcellulose. Kappa carrageenan was as described in Example 2 above.
表IVTable IV
基于藻酸丙二醇酯混合物的组合物
表V报告了用κ-2角叉胶与藻酸丙二醇酯和藻酸钾一起制备的膜的组成和膜性质。κ-2角叉胶是从杉藻(Gigartina skottsbergii)和Sarcothaliacrispata,主要为单倍体(配子体)植物混合物经过碱加工得到的澄清提取物。它也包含约10-20%(相当于总量)来自二倍体(四分孢子体)植物的λ-和θ-角叉胶。Table V reports the composition and film properties of films prepared with kappa-2 carrageenan together with propylene glycol alginate and potassium alginate. Kappa-2 carrageenan is a clarified extract obtained by alkaline processing from Gigartina skottsbergii and Sarcothaliacrispata, a predominantly haploid (gametophytic) plant mixture. It also contains about 10-20% (equivalent to the total amount) of lambda- and theta-carrageenan from diploid (tetrasporocyte) plants.
表VTable V
用κ-2角叉胶制备的藻酸盐膜
在实施例3-4中,钾离子由藻酸钾提供。在角叉胶能形成凝胶膜结构的温度下,钾离子可促进角叉胶双螺旋结构的形成。在实施例3-5中,强度增加而加工粘度下降的原因是藻酸丙二醇酯的含量较高。In Examples 3-4, potassium ions were provided by potassium alginate. At the temperature at which carrageenan can form a gel film structure, potassium ions can promote the formation of carrageenan double helix structure. In Examples 3-5, the increase in strength and decrease in processing viscosity is due to the higher content of propylene glycol alginate.
表VI列出了由低粘性瓜耳胶Edicol ULV 50与藻酸丙二醇酯和其他水胶体形成的组合物和凝胶膜。Protanal酯BV4830和Protanal酯SLF3是藻酸丙二醇酯,可分别购自FMC公司(Philadelphia,PA)和Kibum。SLF-3的分子量小于BV-4830。HEC是羟乙基纤维素。Table VI lists compositions and gel films formed from low viscosity guar gum Edicol ULV 50 with propylene glycol alginate and other hydrocolloids. Protanal® ester BV4830 and Protanal® ester SLF3 are propylene glycol alginate esters available from FMC Corporation (Philadelphia, PA) and Kibum, respectively. SLF-3 has a smaller molecular weight than BV-4830. HEC is hydroxyethylcellulose.
表VITable VI
用藻酸丙二醇酯和瓜耳胶制备的膜
实施例4Example 4
以下实施例说明了用图3所示流体混合设备制备的膜。在这些实施例中,部分A和部分B分别在室温下从各自储存容器作为两股独立的物流4、6泵入两个不同的入口42、44,从这两个入口它们被送入注入蒸气的流体混合设备10中。两股独立的物流4、6在流体混合设备10的混合区52中的蒸气界面上会合。部分A和部分B各自的溶液容易泵入流体混合设备10并与蒸气2混合。蒸气2以120psi的压力进入混合区。所得熔融物或混合浆料8从流体混合设备10的出口56流出。将混合物8倒到光滑表面上,向下拉成均质膜9。The following examples illustrate membranes prepared using the fluid mixing apparatus shown in FIG. 3 . In these examples, Part A and Part B are pumped at room temperature from respective storage containers as two separate streams 4, 6 into two
为测定混合物8的粘度,从出口56收集约500ml混合物8的样品,倒入罐中。在95℃测定此样品的温度、pH和粘度。用Brookfield LVF粘度计测定粘度。采用合适的速度和锭子组合,这样可取读数。将标度上的读数转换为动态粘度(cP)To determine the viscosity of
为测定膜强度和固体含量,从出口56收集熔融物8,用间隙设定为3mm的刮板浇铸到不锈钢板上。收集初始膜9或“新鲜膜”。将几份新鲜膜9放入40℃通风炉,使新鲜膜9干燥。用Texture Analyzer TA-108S Mini Film Test Rig测定浇铸膜条和干燥膜条的断裂力。测定新鲜膜的初始重量和干燥膜的最后重量,通过它们的差确定固体百分含量。To determine film strength and solids content, the
为测定胶凝温度,从混合设备10的出口56收集一部分熔融物8,放入试管,试管有一半是空的。将玻璃温度计插入熔融物8。在室温条件下让材料8冷却。每冷却一度,将温度计从材料8中取出。当观察到材料8的表面上有一个小小的暂时凹痕,记录此温度。将温度计重新插入材料8,让材料进一步冷却。每冷却一度就将温度计取出,然后再插入,直到材料8上形成永久性凹痕,即凹痕不会再被填满。记录形成永久性凹痕时的温度。所报告的胶凝温度是记录的两个温度之间的范围。To determine the gelation temperature, a portion of the
表VIITable VII
包含PGA的混合物
表VII显示,成膜剂可以是水胶体,如角叉胶和PGA的组合。此外,可加入盐来改变膜的性质,如强度、胶凝温度和pH。Table VII shows that the film former can be a hydrocolloid, such as a combination of carrageenan and PGA. In addition, salts can be added to alter membrane properties such as strength, gelation temperature, and pH.
下面的表VIII和IX进一步描述了上述实施例中所述组分。Tables VIII and IX below further describe the components described in the above examples.
表VIIITable VIII
对组分的描述
下表IX描述了本实施例所用的各种角叉胶。Table IX below describes the various carrageenans used in this example.
表IXTable IX
对角叉胶的描述
实施例5Example 5
本发明的输送膜用以下方法制备:将藻酸盐和κ角叉胶干混合形成树胶混合物。KAHG和NAHG分别是自Laminaria hyperborean提取的藻酸的钾盐和钠盐,具有较高的古洛糖醛酸(G)单元水平。KAHM是从Lessonia nigrescens提取的藻酸钾盐,具有较高的甘露糖醛酸(M)单元水平。在1%水溶液中,在25℃测定时,KAHG和KAHM的1%水溶液粘度分别为5cP和12cP。麦芽糖糊精Maltrin M 100(Grain Processing Corporation,Muscatine,Iowa)与树胶混合物干混合。在1.2升不锈钢烧杯中定量加入去离子水和甘油。在充分搅拌下将干燥预混物加入水中,然后加热到90℃,并在90-95℃范围内保持15分钟,以使树胶充分水合。补充因蒸发而损失的水后,加入输送成分,搅拌2分钟以进行分散。用于实验的输送成分有:(1)天然和人工草莓香料(Dragoco,0.1%),(2)二氧化钛,(3)咖啡因。将热溶液快速倒入容器。将浇铸在培养皿中的溶液冷却到室温,形成膜,然后在45℃鼓风炉中干燥过夜,以达到恒重。将样品冷却,然后冷藏(低于8℃)过夜,再用Atago E系列手持式折射仪(Gardco,Pompano Beach,FL)测定凝胶/熔体性质和固体含量。将一小块经过冷藏的凝胶放在丝线支架上,支架固定在试管中,使凝胶块接触不到试管壁,由此测定凝胶的熔化温度。用铝箔覆盖试管,铝箔上开一小孔,以便用数字温度探头测定凝胶的温度。将试管浸没在加热浴中,使凝胶块处在大约100℃的热水浴表面以下。对于熔化温度高于90℃的样品,采用硅油浴。当凝胶样品看上去变湿、变软并能够搅动时,记录熔化温度(记下温度范围)。样品一旦熔化,将试管转移到装有冷自来水(15℃)的第二个烧杯中。在样品冷却的过程中,用温度探头测定温度,并检查样品表面,看样品是否开始胶凝。胶凝温度是样品在冷却的过程中无法再流动,不能将用探头戳出的凹痕填上时的温度。用TextureAnalyzer TA-108S Mini Film Test Rig测定浇铸膜条和干膜条的断裂力(BF)和穿透值。断裂力除以穿透值,就可计算出硬度。The transport membranes of the present invention are prepared by dry mixing alginate and kappa carrageenan to form a gum mixture. KAHG and NAHG are the potassium and sodium salts of alginic acid extracted from Laminaria hyperborean, respectively, with high levels of guluronic acid (G) units. KAHM is a potassium alginate salt extracted from Lessonia nigrescens with a high level of mannuronic acid (M) units. In 1% aqueous solution, when measured at 25°C, the 1% aqueous solution viscosities of KAHG and KAHM are 5cP and 12cP, respectively. Maltodextrin Maltrin M 100 (Grain Processing Corporation, Muscatine, Iowa) was dry blended with the gum mixture. Deionized water and glycerol were dosed in a 1.2-liter stainless steel beaker. Add the dry premix to the water with good agitation, then heat to 90°C and hold at 90-95°C for 15 minutes to fully hydrate the gum. After replenishing the water lost due to evaporation, add the delivery ingredients and stir for 2 minutes to disperse. The delivery ingredients used in the experiments were: (1) natural and artificial strawberry flavor (Dragoco, 0.1%), (2) titanium dioxide, (3) caffeine. Quickly pour hot solution into container. The solution cast in a Petri dish was cooled to room temperature to form a film and then dried in a blast oven at 45°C overnight to achieve constant weight. Samples were cooled and then refrigerated (below 8°C) overnight before gel/melt properties and solids content were determined with an Atago E-Series handheld refractometer (Gardco, Pompano Beach, FL). The melting temperature of the gel is determined by placing a small piece of refrigerated gel on a wire stand fixed in the test tube so that the gel piece does not touch the wall of the test tube. Cover the test tube with aluminum foil with a small hole for the temperature of the gel to be measured with a digital temperature probe. Submerge the test tube in a heating bath so that the gel mass is below the surface of the hot water bath at approximately 100°C. For samples with a melting temperature higher than 90 °C, use a silicone oil bath. When the gel sample appears wet, soft and stirrable, record the melting temperature (note the temperature range). Once the sample had melted, the tube was transferred to a second beaker filled with cold tap water (15°C). While the sample is cooling, measure the temperature with a temperature probe and check the surface of the sample to see if the sample is starting to gel. The gelation temperature is the temperature at which the sample no longer flows and fills the dents poked with the probe during cooling. The breaking force (BF) and breakthrough values of cast and dry film strips were determined with the TextureAnalyzer TA-108S Mini Film Test Rig. The hardness is calculated by dividing the breaking force by the penetration value.
表XITable XI
藻酸盐输送体系
虽然已经结合具体实施方式详细描述了本发明,但本领域的技术人员不难理解,在不背离本发明主旨和范围的前提下,可以做出各种变化和改进。Although the present invention has been described in detail in conjunction with specific embodiments, it is easy for those skilled in the art to understand that various changes and improvements can be made without departing from the spirit and scope of the present invention.
权利要求书claims
(按照条约第19条的修改)(Amended in accordance with Article 19 of the Treaty)
12.如权利要求1所述的输送体系,其特征在于,它具有至少2500g的断裂力强度。12. The delivery system of claim 1 having a breaking force strength of at least 2500 g.
13.如权利要求1所述的输送体系,其特征在于,它具有至少4000g的断裂力强度。13. The delivery system of claim 1 having a breaking force strength of at least 4000 g.
14.如权利要求1所述的输送体系,其特征在于,它具有至少5000g的断裂力强度。14. The delivery system of claim 1 having a breaking force strength of at least 5000 g.
15.如权利要求1所述的输送体系,其特征在于,它具有至少6000g的断裂力强度。15. The delivery system of claim 1 having a breaking force strength of at least 6000 g.
16.制备权利要求1-15所述均质凝胶膜输送体系的方法,它包括如下步骤:16. The method for preparing the homogeneous gel membrane delivery system of claims 1-15, comprising the steps of:
(i)在提供足够剪切力、温度和保留时间的设备中对所述藻酸盐,以及增塑剂、第二成膜剂、增量剂和pH控制剂中至少任选一种的进行加热、水合、混合、溶解和任选的脱气,形成均质熔融组合物,其中所述温度等于或高于所述组合物的溶解温度;(i) carry out at least one of said alginate, and plasticizer, second film-forming agent, bulking agent and pH control agent in equipment providing sufficient shearing force, temperature and retention time heating, hydrating, mixing, dissolving and optionally degassing to form a homogeneous molten composition, wherein said temperature is equal to or higher than the dissolution temperature of said composition;
(ii)在形成熔融组合物之前或之后加入有效量的活性物质;(ii) adding an effective amount of active material before or after forming the molten composition;
(iii)冷却含所述活性物质的所述熔融组合物至等于或低于其胶凝温度,形成含所述活性物质的所述凝胶膜。(iii) cooling said molten composition containing said active material to be at or below its gelling temperature to form said gel film containing said active material.
17.如权利要求16所述的方法,其特征在于,所述活性物质是口腔护理剂、呼吸清新剂、药剂、营养剂、唾液分泌刺激剂、维生素、矿物质、化妆成分、农用活性成分、着色剂、甜味剂、调味剂、香料或食物中的至少一种。17. The method of claim 16, wherein the active substance is an oral care agent, a breath freshener, a medicament, a nutritional agent, a salivation stimulator, a vitamin, a mineral, a cosmetic ingredient, an agricultural active ingredient, At least one of coloring agent, sweetener, flavoring agent, spice or food.
18.如权利要求16所述的方法,其特征在于,所述设备是Ross混合器,挤塑机,Stephan处理机,射流锅炉或流体混合设备。18. The method of claim 16, wherein the equipment is a Ross mixer, extruder, Stephan processor, jet boiler or fluid mixing equipment.
19.如权利要求1所述的输送体系,其特征在于,它具有至少250g的断裂力强度。19. The delivery system of claim 1 having a breaking force strength of at least 250 g.
20.如权利要求1所述的输送体系,其特征在于,它具有至少1000g的断裂力强度。20. The delivery system of claim 1 having a breaking force strength of at least 1000 g.
21.如权利要求1所述的输送体系,所述体系还包含调味剂,并且固体含量至少为50%。21. The delivery system of claim 1 further comprising a flavoring agent and having a solids content of at least 50%.
22.如权利要求1所述的输送体系,其特征在于,所述第二成膜剂是一种角叉胶,在含基于所述溶液的所有组分重量的1.5%所述角叉胶的0.10摩尔氯化钠水溶液中测定时,所述角叉胶在75℃的粘度小于10 cp。22. The delivery system of claim 1, wherein said second film former is a carrageenan in an amount of 1.5% said carrageenan based on the weight of all components of said solution. When measured in 0.10 mole sodium chloride aqueous solution, the viscosity of described carrageenan at 75 ℃ is less than 10 cp.
23.如权利要求1所述的输送体系,其特征在于,所述凝胶膜不含增塑剂。23. The delivery system of claim 1, wherein the gel film is free of plasticizers.
24.如权利要求1所述的输送体系,它由所述水溶性热可逆藻酸盐、增量剂、活性物质和水组成。24. The delivery system of claim 1, consisting of said water-soluble thermoreversible alginate, a bulking agent, an active substance and water.
25.权利要求24所述输送体系,其特征在于所述增量剂是玉米糖浆。25. The delivery system of claim 24, wherein said bulking agent is corn syrup.
Claims (22)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46272103P | 2003-04-14 | 2003-04-14 | |
| US60/462,785 | 2003-04-14 | ||
| US60/462,794 | 2003-04-14 | ||
| US60/462,792 | 2003-04-14 | ||
| US60/462,758 | 2003-04-14 | ||
| US60/462,721 | 2003-04-14 | ||
| US60/462,617 | 2003-04-14 | ||
| US60/462,783 | 2003-04-14 | ||
| US60/462,793 | 2003-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1791385A true CN1791385A (en) | 2006-06-21 |
Family
ID=36788720
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200480014006 Pending CN1791385A (en) | 2003-04-14 | 2004-04-14 | Homogeneous, thermoreversible alginate films transportation system |
| CN 200480013903 Pending CN1791382A (en) | 2003-04-14 | 2004-04-14 | Process for making gel films |
| CN 200480014023 Pending CN1794979A (en) | 2003-04-14 | 2004-04-14 | Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom. |
| CNB2004800139076A Expired - Lifetime CN100569224C (en) | 2003-04-14 | 2004-04-14 | Homogeneous thermally reversible gel film containing k-2 carrageenan and soft capsule prepared therefrom |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200480013903 Pending CN1791382A (en) | 2003-04-14 | 2004-04-14 | Process for making gel films |
| CN 200480014023 Pending CN1794979A (en) | 2003-04-14 | 2004-04-14 | Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom. |
| CNB2004800139076A Expired - Lifetime CN100569224C (en) | 2003-04-14 | 2004-04-14 | Homogeneous thermally reversible gel film containing k-2 carrageenan and soft capsule prepared therefrom |
Country Status (1)
| Country | Link |
|---|---|
| CN (4) | CN1791385A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114762527A (en) * | 2021-01-15 | 2022-07-19 | 广东富味健康科技有限公司 | Refreshing tablet containing active probiotics and preparation method thereof |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102206362B (en) * | 2011-04-28 | 2012-06-27 | 福建农林大学 | Instant noodle flavoring package coating and preparation method thereof |
| US20200221752A1 (en) * | 2013-09-13 | 2020-07-16 | Phood Station | Encapsulated food products and methods of making same |
| CN105534945B (en) * | 2015-12-29 | 2020-12-25 | 仙乐健康科技股份有限公司 | Plant type enteric soft capsule |
| US9878039B1 (en) | 2016-09-01 | 2018-01-30 | International Business Machines Corporation | Microcapsule having a microcapsule shell material that is rupturable via a retro-dimerization reaction |
| US10328535B2 (en) | 2016-11-07 | 2019-06-25 | International Business Machines Corporation | Self-heating solder flux material |
| CN107982095B (en) * | 2017-10-19 | 2020-03-27 | 珀莱雅化妆品股份有限公司 | Preparation method of sustained-release solid microspheres with anti-wrinkle effect |
| CN117652652A (en) * | 2023-12-18 | 2024-03-08 | 湖北一致魔芋生物科技股份有限公司 | Gel particles and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089307A (en) * | 1989-05-23 | 1992-02-18 | Mitsubishi Rayon Co., Ltd. | Edible film and method of making same |
| US5342626A (en) * | 1993-04-27 | 1994-08-30 | Merck & Co., Inc. | Composition and process for gelatin-free soft capsules |
| FR2767070B1 (en) * | 1997-08-08 | 1999-09-17 | Laurence Paris | AQUEOUS VISCOUS COMPOSITION, LIMPID OR NOT, FOR THE MANUFACTURE OF SOFT CAPSULES AND HARD CAPSULES, AND METHOD FOR MANUFACTURING FILMS FOR SUCH CAPSULES |
| US6214376B1 (en) * | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
-
2004
- 2004-04-14 CN CN 200480014006 patent/CN1791385A/en active Pending
- 2004-04-14 CN CN 200480013903 patent/CN1791382A/en active Pending
- 2004-04-14 CN CN 200480014023 patent/CN1794979A/en active Pending
- 2004-04-14 CN CNB2004800139076A patent/CN100569224C/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114762527A (en) * | 2021-01-15 | 2022-07-19 | 广东富味健康科技有限公司 | Refreshing tablet containing active probiotics and preparation method thereof |
| CN114762527B (en) * | 2021-01-15 | 2023-07-25 | 广东富味健康科技有限公司 | Tasty and refreshing tablet containing active probiotics and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1794979A (en) | 2006-06-28 |
| CN1791382A (en) | 2006-06-21 |
| CN1791389A (en) | 2006-06-21 |
| CN100569224C (en) | 2009-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4558721B2 (en) | Uniform and thermoreversible gel film containing kappa-2 carrageenan and soft capsule made therefrom | |
| US7816341B2 (en) | Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom | |
| US20090208569A1 (en) | Homogeneous, Thermoreversible Alginate Films and Soft Capsules Made Therefrom | |
| US20050013847A1 (en) | Delivery systems of homogeneous, thermoreversible alginate films | |
| CN1791417A (en) | Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films | |
| CN1791385A (en) | Homogeneous, thermoreversible alginate films transportation system | |
| US20050019295A1 (en) | Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom | |
| CN1791388A (en) | Homogeneous, thermoreversible alginate films and soft capsules made therefrom | |
| RU2341290C2 (en) | Homogeneous, thermally reversible gel containing carragenan of underviscosity, and products made thereof | |
| RU2341250C2 (en) | Homogeneous thermal reversible gel film containing cappa-2-carraginan, and soft capsules produced thereof | |
| ZA200508253B (en) | Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |